Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia.

about

Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia.

Item

http://www.wikidata.org/entity/Q47706549

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Current challenges and opportu ...... acute lymphoblastic leukaemia.

@en

Current challenges and opportu ...... acute lymphoblastic leukaemia.

@nl

type

Item

label

Current challenges and opportu ...... acute lymphoblastic leukaemia.

@en

Current challenges and opportu ...... acute lymphoblastic leukaemia.

@nl

prefLabel

Current challenges and opportu ...... acute lymphoblastic leukaemia.

@en

Current challenges and opportu ...... acute lymphoblastic leukaemia.

@nl

P1476

Current challenges and opportu ...... acute lymphoblastic leukaemia

@en

P2093

Daniel J DeAngelo

http://www.w3.org/2001/XMLSchema#string

Irina Amitai

http://www.w3.org/2001/XMLSchema#string

P2860

Treating childhood acute lymphoblastic leukemia without cranial irradiation

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies

Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.

Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: an individual patient data meta-analysis.

Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials.

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.

Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group Study.

Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.

P304

705-723

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14916

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

179

http://www.w3.org/2001/XMLSchema#string

P50

Ofir Wolach

P577

2017-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29076138

http://www.w3.org/2001/XMLSchema#string

P921

leukemia